Delivery Order SPE2DR25D1104-SPE2DR26FK507
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,807.26 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price contract, issued on October 31, 2025, with completion by November 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Opzelura 1.5% cream in a 60-gram quantity, with a ceiling value of $1,381.02 and a firm fixed price structure. This award represents a non-set-aside, competitively awarded delivery order under a child contract vehicle, with an ultimate completion date of December 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,762.04 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram format. This firm fixed price contract, with an ultimate completion date of December 12, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $3,929.92 delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $45,518.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams), with an ultimate completion date of November 25, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Opzelura 1.5% cream in a 60-gram quantity, with a contract ceiling value of $8,660.52 and an ultimate completion date of December 3, 2025. This non-set-aside delivery order represents a single-day procurement action typical of the agency's medical supply chain operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $8,412.67 delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams), with an ultimate completion date of December 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The award represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $7,101.39 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% cream in 60-gram quantities. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK507Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,612.67 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in a 60-gram unit. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical procurement supporting federal medical supply chain operations. The award was made on a non-set-aside, competitive basis to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving the Defense Health Agency and other federal healthcare systems, AmerisourceBergen leverages this strategic IDC vehicle to fulfill diverse medical supply requirements across multiple therapeutic domains for military and veteran healthcare programs. The current delivery order for Opzelura, a dermatological treatment product, exemplifies the company's ongoing role in supporting federal medical procurement needs through flexible and competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 11/24/25 |